I agree that this site is using cookies. You can find further informations here.
X
Al Zir, Kusai
8  results:
Search for persons X
?
1

Multicenter validation of spin‐density projection‐assisted ..:

St Pierre, Tim G. ; El‐Beshlawy, Amal ; Elalfy, Mohsen...
Magnetic Resonance in Medicine.  71 (2013)  6 - p. 2215-2223 , 2013
Link: https://doi.org/10.1002/..
 
?
2

Achieving treatment goals of reducing or maintaining body i..:

Taher, Ali ; Elalfy, Mohsen S. ; Al Zir, Kusai...
European Journal of Haematology.  87 (2011)  4 - p. 349-354 , 2011
Link: https://doi.org/10.1111/..
 
?
3

Importance of optimal dosing ≥30 mg/kg/d during deferasirox..:

Taher, Ali ; Elalfy, Mohsen S. ; Al Zir, Kusai...
European Journal of Haematology.  87 (2011)  4 - p. 355-365 , 2011
Link: https://doi.org/10.1111/..
 
?
4

Efficacy and safety of deferasirox, an oral iron chelator, ..:

Taher, Ali ; El-Beshlawy, Amal ; Elalfy, Mohsen S....
European Journal of Haematology.  82 (2009)  6 - p. 458-465 , 2009
Link: https://doi.org/10.1111/..
 
?
5

Multicenter Validation of Spin-Density Projection-Assisted ..:

St Pierre, Tim G ; El-Beshlawy, Amal ; Elalfy, Mohsen...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2014
Link: http://www.ncbi.nlm.nih...
 
?
6

Importance of optimal dosing ≥30 mg/kg/d during deferasirox..:

Taher, Ali ; Elalfy, Mohsen S ; Al Zir, Kusai...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229712.  , 2011
Link: http://www.ncbi.nlm.nih...
 
?
7

Achieving treatment goals of reducing or maintaining body i..:

Taher, Ali ; Elalfy, Mohsen S ; Al Zir, Kusai...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229710.  , 2011
Link: http://www.ncbi.nlm.nih...
 
?
8

Efficacy and safety of deferasirox, an oral iron chelator, ..:

Taher, Ali ; El-Beshlawy, Amal ; Elalfy, Mohsen S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730551.  , 2009
Link: http://www.ncbi.nlm.nih...
 
1-8